Staying current
and connected

See what we are doing, where we are going, and how we are shaping our industry every day.

Introducing ComplEYE Drops™ MDB

Now joining our family of top-selling combination drops, Pine Pharmaceuticals is excited to announce our all-new 3 in 1 post-op drop ComplEYE Drops™ MDB (Moxifloxacin 0.5%–Dexamethasone 0.1%–Bromfenac 0.035%). This easy-to-manage solution combines an antibiotic,...

2024 Conferences and Trade Shows

March 8 - 10, 2024 Phoenix, AZ Learn moreApril 5 - 8, 2024 Boston, MA Learn moreApril 8 - 10, 2024 Dallas, TX Learn moreJune 8 - 12, 2024 Portland, OR Learn moreMay 17 - 20, 2023 Louisville, KY Learn moreJuly 17, 2024 Stockholm, Sweden Learn moreAugust 4 - 5, 2024...

MasterControl Award: Excellence in Analytics

We're excited to announce that Pine Pharmaceuticals has been honored with the Excellence in Analytics award by MasterControl.  Spearheaded by our Innovation and Development Manager, James Ando, Pharm.D., MasterControl has been pivotal in transforming our reports into...

Compounding Pharmacy Compliance Conference 2023

We're thrilled to announce that our Director of Pharmacy Services and Regulatory Affairs, Allison Gentile, Pharm.D., will be a featured speaker at this year's Compounding Pharmacy Compliance 2023 event on August 17-18th. Learn more and see the full agenda here.

Pine Pharmaceuticals wins Brick by Brick Award

We're thrilled to announce that Buffalo Business First awarded Pine Pharmaceuticals a Brick by Brick award, recognizing our 50,000-square-foot expansion. These exclusive awards highlight the accomplishments of Western New York's real estate development industry. Thank...

Introducing StaClear® Luer Slip and Norm-Ject® Less Fill

Pine Pharmaceuticals is pleased to introduce StaClear® Luer Slip and NORM-JECT® Less Fill, our all-new syringe options for repackaged bevacizumab. Designed to provide exceptional quality, StaClear® Luer Slip and NORM-JECT® Less Fill syringes now offer a low dead space...